Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2021 · 10-Q
Revenue$243.55M$243.55M+25.1% vs Q3 2020 Net Income$45.78M$45.78M+25.7% vs Q3 2020 EPS Diluted$1.12$1.12+21.7% vs Q3 2020 Gross Profit$168,274,000+29.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$74,866,000+51.3% Free Cash Flowderived$64,264,000+59.9% Margins · derivedGross margin69.1%+2.3 pt vs Q3 2020
Operating margin28.2%+3.6 pt vs Q3 2020
Net margin18.8%+0.1 pt vs Q3 2020
ended Mar 31, 2021 · filed May 7, 2021 · 37 d after period end